umbrellalabs MK-2866 OSTARINE SARM 30 ML

Ostarine (Enobosarm) is a non-steroidal selective androgen receptor modulator (SARM) being studied for its potential to enhance lean muscle mass, strength, and physical function. It is also under research for conditions such as osteoporosis, urinary incontinence, and certain cancers. In two major Phase 2 clinical trials, Ostarine produced significant increases in lean body mass and strength across diverse populations. In the first trial, involving healthy elderly men and postmenopausal women, doses up to 3 mg daily led to measurable gains in lean muscle, reduced fat mass, and improved physical performance as measured by stair-climb tests. The study showed dose-dependent effects and confirmed safety, with no significant androgenic side effects or changes in free teststerone levels. Additionally, Ostarine displayed potential benefits for glucose metabolism and insulin resistance, showing reductions in fasting glucose and insulin comparable to standard diabetes treatments. Lipid profile improvements were also noted, including reductions in cholesterol and triglycerides. A second Phase 2 trial, focused on patients with muscle wasting, reinforced these findings. Participants taking 1 mg or 3 mg doses experienced statistically significant increases in lean body mass and stair-climb power, without notable changes in PSA levels or hair growth. The treatment was well tolerated, with transient and mild changes in liver enzymes that resolved without discontinuation. Ostarine’s safety profile and anabolic effects make it a promising research compound for conditions involving muscle loss and functional decline. Studies also highlight its potential dual benefit on muscle and bone, suggesting future therapeutic relevance in age-related sarcopenia and osteoporosis. **Key Findings:** * Promotes lean muscle growth and strength across age groups * Improves insulin sensitivity and lipid metabolism * Demonstrates strong safety and tolerability * Enhances physical function and mobility * May support bone health and muscle preservation Overall, Ostarine continues to show clinical promise as a novel therapeutic candidate for muscle-wasting conditions and metabolic support in both healthy and clinical populations.